v3.25.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Retained earnings
Accumulated other comprehensive (loss) income
Non-controlling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance $ 902,666     $ 344,568     $ 642,817 $ (84,719) $ 0
Ending balance 902,666     344,568     642,817 (84,719) 0
Beginning balance (in shares) at Dec. 31, 2023         44,617,673 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 27,586           27,586    
Other comprehensive income (loss) (6,518)             (6,518)  
Issuance of restricted stock (in shares)         123,670        
Tax withholding related to vesting of restricted stock and other (3,057)     (3,057)          
Employee stock purchase program (in shares)         18,485        
Employee stock purchase program 702     702          
Stock option exercises (in shares)         178,845        
Stock option exercises 1,129     1,129          
Restricted stock compensation expense 6,306     6,306          
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 249           249    
Cash dividends (1,345)           (1,345)    
Ending balance (in shares) at Mar. 31, 2024         44,938,673 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance 927,718     349,648     669,307 (91,237) 0
Ending balance 927,718     349,648     669,307 (91,237) 0
Beginning balance 1,003,496     365,607     715,767 (82,344) 4,466
Ending balance 1,003,496     365,607     715,767 (82,344) 4,466
Beginning balance (in shares) at Dec. 31, 2024   45,359,425 0   45,359,425 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 9,668           9,717   (49)
Other comprehensive income (loss) 14,646             14,646  
Issuance of restricted stock (in shares)         143,784        
Tax withholding related to vesting of restricted stock and other (3,178)     (3,178)          
Employee stock purchase program (in shares)         23,015        
Employee stock purchase program 659     659          
Stock option exercises (in shares)         63,409        
Stock option exercises 758     758          
Restricted stock compensation expense 6,667     6,667          
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 98           98    
Cash dividends (1,367)           (1,367)    
Ending balance (in shares) at Mar. 31, 2025   45,589,633 0   45,589,633 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Beginning balance 1,031,447     370,513     724,215 (67,698) 4,417
Ending balance $ 1,031,447     $ 370,513     $ 724,215 $ (67,698) $ 4,417